Yearly Archives: 2013

Need Antibodies for That Luminex Assay? Try These Resources to Find Potential Suppliers and User Reviews

12月 20th, 2013 / Cassie Bannister

Off the Shelf Kits and Reagents for Luminex-Based Proteomic Assays While the Luminex platform can be used for

Continue reading »

How Luminex xMAP® Technology is Changing HIV Drug Resistance Research

12月 12th, 2013 / Cassie Bannister

Scanning electromicrograph of an HIV-infected T cell. HIV Infected T cell by NIAID is licensed under Creative

Continue reading »

Tech Tuesday: We’re ready to go above and beyond for you!

12月 10th, 2013 / Cassie Bannister

Luminex is not only known for the assays based on its proprietary xMAP® Technology, but also exceptional custo

Continue reading »

Multiplex Immunoassay Development for Detection of Organic Pollutants in Fish

12月 4th, 2013 / Cassie Bannister

Kelley Hotspring Fish Farm (Tilapia) by USDA NRCS is licensed under Creative Commons License Tilapia farming i

Continue reading »

SA-PE: Where Lasers and Algae Meet

11月 19th, 2013 / David Polchert

There are two light sources used to collect data from samples in xMAP® Technology based assays. The red light

Continue reading »

Now That You’re Implementing xTAG® GPP, Are You Ready for Training?

11月 5th, 2013 / Cassie Bannister

To the delight of patients and medical physicians, you’ve opted to implement the FDA Cleared Luminex xTAG® GPP

Continue reading »

Septicemia Highlighted as Most Expensive Condition Treated in U.S.

11月 4th, 2013 / Nanosphere, A Luminex Company

A recent report from the Healthcare Cost and Utilization Project (HCUP) listed septicemia as the most expensive condition treated in U.S. hospitals. The HCUP Statistical Brief #160 describes the distribution of costs by expected primary payer and illustrates the conditions responsible for the greatest percentage of each payer’s hospital costs. Primary payers include Medicaid, Medicare, private insurance, and the uninsured.

Continue reading »

Multiplex Technologies More Effective than ELISA for Antibody Detection

10月 31st, 2013 / Cassie Bannister

The results of a recent AIDS vaccine trial, RV144, have given researchers a clue about how to successfully ino

Continue reading »

New Study in JCM Characterizes the Performance of the Verigene Clostridium difficile Test

10月 28th, 2013 / Nanosphere, A Luminex Company

A recent publication by Karen Carroll et al. in the Journal of Clinical Microbiology (JCM) characterized the performance of the Verigene® Clostridium difficile Nucleic Acid Test (CDF) by comparing CDF results versus both direct and enriched toxigenic culture on stool specimens from patients suspected of having C. difficile infection. A total of 1,875 specimens were analyzed in the multi-center study.

Continue reading »

Why Are Most Scientific Presentations Boring?

10月 24th, 2013 / Luminex Corporation

Every scientist has had the pleasure of hearing a sleep-inducing, data-laden presentation. While there may be

Continue reading »